Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

The management teams of the University of the Free State and the Vista University Bloemfontein campus set the wheels rolling for the incorporation of
2003-05-22

The management teams of the University of the Free State and the Vista University Bloemfontein campus set the wheels rolling for the incorporation of the Vista Bloemfontein campus into the UFS.

The incorporation process will be dealt with in two phases. The first phase would be preparing for a possible incorporation on 1 January 2004, including possible streamlining and review of programmes. The second phase would be part of developing the long term vision or optimal reconfiguration of the Vista facility (within the UFS as a multi-campus institution) in the interests of higher education in the Free State and the communities surrounding the two campuses in Bloemfontein.

At a meeting at the UFS both parties reached consensus about the process and set about establishing task teams to deal with critical issues, such as governance and management, financial management, human resources, information systems, library services, student support and administration, academic planning and academic programmes.

Prof Talvin Schultz, Head of the Vista Bloemfontein campus, committed this campus to making the process of incorporation into the UFS an exemplary process. UFS Rector Prof Frederick Fourie said the Free State should continue its tradition as a province where things happen and where higher education transformation has proceeded faster than elsewhere in the country.

Both emphasised the need for an inclusive process of consultation with staff, students and the community on key aspects of the incorporation.

They indicated that all planning should take into account a possible date of incorporation of 1 January 2004, pending finalisation by the respective Councils. The Councils of both institutions need to give feedback to the Minister of Education on the date of incorporation by the end of June, and the task teams must deliver an initial report on progress before then.


Prof Talvin Schultz (Vista Bloemfontein campus) and Prof Frederick Fourie (UFS)

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept